Antithrombin deficiency, whether inherited or acquired, poses a significant risk factor for venous thromboembolism (VTE) by impairing the natural regulation of coagulation. As a critical plasma ...
Thrombate III is the only antithrombin concentrate approved in both adult and pediatric patients for hereditary antithrombin deficiency. The Food and Drug Administration (FDA) has expanded the ...
ATryn Available for Patients with Hereditary Antithrombin Deficiency, a Rare Blood Clotting Disorder
DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark (LUN: Copenhagen Stock Exchange), announced today that ATryn ® (Antithrombin [Recombinant]) is ...
BOSTON, Mass., July 16, 2009– Data presented at the annual meeting of the International Society on Thrombosis and Haemostasis (ISTH) in Boston show that ATryn® (Antithrombin [Recombinant]) safely ...
When to treat patients with heparin and when to treat using an antithrombin concentrate; Why it is important to aggressively treat patients with type one antithrombin deficiency who have already ...
In June 2021, Kenneth A. Bauer, MD, from Beth Israel Deaconess Medical Center and professor of medicine at Harvard Medical School, spoke with Healio about the diagnosis and treatment of hereditary ...
INNOVANCE Antithrombin assay is a cutting-edge, ready-to-use chromogenic reagent for the automated determination of antithrombin (AT) activity. It is highly accurate even at low activity levels and ...
The authors review 8 cases of thrombosis in uncommon sites caused by protein S deficiency. Hypercoagulability, venous stasis, and vessel wall injury predispose to thrombus formation. Thrombophilia can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback